Skip to main content
1005-2014, 1001-2003
class com.aha.ucm.component.cis.TagListPageData=[,docNativeURL=null,docName=UCM_504531,docStatus=RELEASED,dOutDate=null,docSSFileName=UCM_504531_ATVB-Featured-Articles--August-2019.jsp,docTitle=ATVB | Featured Articles | August 2019,xWebsites=professional,dDocAuthor=stacey.sims,xNextReviewDate=09/22/2016 5:42 PM,xTier1=36,xFeaturedItem=No,xElectronicRegistration=No,UserLocale=null,xSubCategory=,dpEvent=null,xComments=ATVB August 2019 Editor's Pick and Featured Article,NoHttpHeaders=null,UserTimeZone=null,xRegionDefinition=GENERIC_RD_COL_1,xVideoRenditions=,xSnippetItem=,xNotes=,UserDateFormat=null,encodeDocUrl=null,isDocProfileDone=null,xKeywords=,xTier2=,refreshSubMonikers=null,xEditorStepReassignedUsers=null,xLinkTextToDisplay=,dDocAccount=WCM/SOP/SPUB,xEndDateTime=null,xClbraAliasList=null,ClientEncoding=null,xCpdIsLocked=0,xUsageRightsDate=null,xModifyDate=07/25/2019 11:14 PM,xTier3=,xEventDate=null,dSubscriptionType=null,xCopyright=No,xPackagedConversions=,dSubscriptionAlias=null,xStorageRule=,dpName=null,xDepartment=Science Operations,dStatus=RELEASED,dPublishType=,xCopyrightDetails=,xSubType=64,isDocProfileUsed=null,xWebsiteObjectType=Data File,xWebFlag=,xSeeAlsoLinks=,xClbraUserList=null,xPartitionId=,xCpdIsTemplateEnabled=0,xLinkWebAddress=,xDontShowInListsForWebsites=,xStartDateTime=null,dInDate=07/25/2019 10:52 PM,xWebsiteSection=professional:1463,dDocName=UCM_504531,dpAction=null,dRevLabel=1,dSecurityGroup=AHAMAH-Public,xCategory=,refreshMonikers=null,xDamConversionType=,dDocFormats=null,xAssociatedImage=,dDocType=SingleColumn,xBusinessOwner=Business Owner,xUploadDate=null,xDiscussionCount=0,xMainFlowEntryCriteria=True,xItemInformation=,xUsageRights=,xDiscussionType=N/A,xRecipeTaxonomy=,dSubscriptionID=null,dOriginalName=UCM_504531.xml,xProfileTrigger=SingleColumn,dLocation=,dRevisionID=1,dPublishState=,dReleaseState=Y,xTrashDeleter=null,dMessage=,dWebExtension=xml,dExtension=xml,dProcessingState=Y,xTrashDeleteName=null,dIsCheckedOut=0,xForceFolderSecurity=null,dRevClassID=504531,dIsPrimary=1,dFileSize=9266,dIndexerState=,dFlag1=,xviaAddNewContentService=,dIsWebFormat=0,xCollectionID=null,dRevRank=0,xReadOnly=null,dCheckoutUser=,dFormat=Application/xml,dWorkflowState=,dDocID=1897029,dRendition2=,dRendition1=,xInhibitUpdate=null,dReleaseDate=07/25/2019 11:15 PM,xTrashDeleteLoc=null,dCreateDate=07/25/2019 11:14 PM,xHidden=null,labelTier1=ScienceNews,labelTier2=,labelTier3=,labelTier4=,mobileNavURL=DEFAULT2_VALUE_FROM_getDataForAdvanceSearch,xContactPhoneNumber=,xContactEmailAddress=,xContactName=,xATGRolesDisciplines=,xPublishDate=07/25/2019 5:00 AM,xRobotParameter=,xCommunities=1005-2014, 1001-2003,xMembershipLevel=,rsCalories=null,rsSodium=null,rsRecipeTaxonomy=null,rsServings=null,rsTotalTime=null,rsTotalFat=null,rsTotalCarbs=null,rsFeaturedImage=null,xDisplayComments=

Featured Articles
August 2019

About the Cover

 

About the Cover

Interleukin-1ß structure. Art can imitate and enrich life: This detail depicts, in stained glass, the ribbon structure of the proinflammatory cytokine IL-1ß, as commissioned by Dr Peter Libby and executed by Dr Joel Kowit. (See pages 1510–1519.)
https://www.ahajournals.org/doi/10.1161/ATVBAHA.119.311998

Editor's Pick



Endothelial Mineralocorticoid Receptors Contribute to Vascular Inflammation in Atherosclerosis in a Sex-Specific Manner

Editor's Note:
In this article, the authors explore the role of the Mineralocorticoid receptor (MR) in atherosclerosis using multiple state-of-the-art techniques. One important finding is that endothelial MR contributes to inflammation in atherosclerosis differentially between male and female mice, highlighting sex difference in MR-mediated mechanism of atherosclerosis.

 
 

Featured Articles


Inhibition of CHK1 Elicits Therapeutic Effects in Pulmonary Arterial Hypertension
 
CHK1 overexpression mitigates DNA damage and exerts pro-proliferative functions in PAH-PASMCs, suggesting it as a potential target for improving pulmonary vascular remodeling in PAH.

 


Inhibition of VEGF-A or its receptor activity suppresses experimental aneurysm progression in the aortic elastase infusion model
  
FDA-approved angiogenesis inhibitor sunitinib limits progression of established experimental aortic aneurysms, suggesting a potential translational application for non-surgical management of AAA disease.

Related Links